Three Virtues Initiative Strives to Transform African-American Health and Wellness

African-Americans are disproportionately affected by many diseases and Pfizer is committed to improving health among this segment of the population.

Three Virtues is our integrated, enterprise-wide initiative aiming to:

1. Achieve a measurable reduction in health disparities, increase clinical trial participation and improve health outcomes for African-Americans
2. Establish a robust pipeline of African-American talent and leverage the insights of African-American colleagues to more effectively engage the African-American community
3. Build a strong reputation in the African-American community based on consistent efforts to address health and wellness needs

Three Virtues achieved several important milestones in 2018, including co-publishing the African-American Engagement Study with the National Medical Association and National Black Nurses Association.

We are leveraging our medicines to close diagnosis and treatment gaps for African-Americans in diabetic peripheral neuropathy, smoking cessation and atopic dermatitis. We are applying African-American patient perspectives in the clinical development of a product for sickle cell disease. And to increase African-American participation in clinical trials, both as patients and investigators, we are evaluating if collaboration between academia, an urban-based hospital and industry can generate compelling results.